WEARABLE HEALTH SOLUTIONS, INC.
OperatingIndustrial & Manufacturing · Mequon, WI
Financials
FY2011–FY2023 (no data for FY2017, FY2020) · from SEC filings · hover any figure for its sourceChart shows the most recent 8 fiscal years; 3 earlier years are in the table below.
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Dec 31, 2023| Class | Outstanding | Votes / share | Converts | As converted | Votes | Last price |
|---|---|---|---|---|---|---|
| Series E Preferred Stockpreferred | 4,000,000 | 10,000 | 100 × Common Stock | 17.2% | 95.6% | — |
| Series C Preferred Stockpreferred | 5,676,839 | none | 10 × Common Stock | 2.44% | 0% | — |
| Series D Preferred Stockpreferred(as of Jun 9, 2023) | 425,000 | none | 100 × Common Stock | 1.83% | 0% | — |
| Series B Convertible Preferred Stockpreferred(as of Jun 9, 2023) | 9,938 | none | 2 × Common Stock | 0% | 0% | — |
| Preferred Stockpreferred(as of Mar 31, 2023) | 9,938 | — | — | 0% | 0% | — |
| Series A Convertible Preferred Stockpreferred(as of Jun 9, 2023) | 688 | none | 2 × Common Stock | 0% | 0% | — |
| Common Stock | 1,826,705,108 | 1 | — | 78.5% | 4.37% | $0.01Sep 2020 |
| Total | 1,836,827,511 | 2,326,004,688 as converted | 100% | 100% |
Shares outstanding over timein today's share terms
Changes in named holdersshares in today's terms · % of all shares at the time
- Vincent S. Miceli5.3M (104.3%) Oct 2022 → 6.3M (123.1%) Mar 2023
- Harrysen Mittler500K (31.6%) Sep 2020 → 2.0M (39.0%) Oct 2022 → 303M (16.7%) Oct 2023
- Peter Pizzino500K (31.6%) Sep 2020 → 2.0M (39.0%) Oct 2022 → 303M (16.7%) Oct 2023
- Ronald Adams18K (1.06%) Aug 2013 → 15M (145904.6%) Mar 2014 → 634K (6381.2%) Jul 2014 → 31M (61.4%) Oct 2016
- Alan Polsky9K (0.55%) Aug 2013 → 7.5M (75971.0%) Mar 2014 → 227K (2289.0%) Nov 2014 → 2.7M (5.47%) Oct 2016
- Biotech Debt Liquidation Fund, LLC541K (5446.8%) Jul 2014 → 493K (6.25%) Dec 2015
- As of November488K (2374.0%) Dec 2013 → 391M (3929834.0%) Mar 2014
- Ronnie Adams12K (27.0%) Oct 2009 → 30K (68.8%) Nov 2010
Principal holders% as the filing states it, Oct 20, 2023
- Harrysen Mittler303,175,000 Common Stock17.2%of
- Peter Pizzino303,175,000 Common Stock17.2%of
- Vincent S. Miceli6,312,500 Common Stock—of votes
Sold to the crowd
- Reg A+ · Sep 2020500,000,000 Common Stock at $0.01$5M
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. “As converted” counts each class in the shares it converts into. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
3 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
View all 88 filings on EDGAR- Form 10-QFeb 20, 20240001683168-24-001084EDGAR
- Form 10-QNov 20, 20230001683168-23-008356EDGAR
- Form 10-KOct 20, 20230001683168-23-007319EDGAR
- Form QUALIFJun 27, 20239999999994-23-000240EDGAR
- Form 1-A POSJun 9, 20230001683168-23-004051EDGAR
- Form 10-QMay 22, 20230001683168-23-003638EDGAR
- Form 253G2Apr 19, 20230001683168-23-002518EDGAR
- Form QUALIFApr 7, 20239999999994-23-000152EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.